PROCESS FOR THE PREPARATION OF 1,1-CYCLOHEXANE DLACETIC ACID MONOAMIDE
Field of the Invention
This invention relates to an improved process for the preparation of 1,1-cyclohexane-diacetic acid monoamide (CHDAAM) which is a starting material for the production of l-(aminomethyl)cyclohexaneacetic acid, which is a pharmaceutical compound known as Gabapentin.
Background of the Invention
Skilled persons know how to prepare CHDAAM by the amination of cyclohexanediacetic anhydride (hereinafter CHDAAn), which in turn can be prepared from cyclohexanediacetic acid (hereinafter CHDAA). TJSP 4,024,175 describes the preparation of 1,1-cyelopentanediacetic acid monoamide from 1,1-cyclopentenediacetic anhydride. The amination is carried out by reacting the anhydride with a 20% aqueous solution of ammonia and, after the reaction has taken place, removing the excess ammonia in a vacuum, acidifying the solution with hydrochloric acid, and then extracting with methylene chloride. Subsequently, the methylene chloride is stripped off to provide 1,1-cyclopentanediacetic acid monoamide.
A similar reaction would produce CHDAAM if the starting material were 1,1 -cyclohexanediacetic anhydride. The reaction, for the preparation of CHDAAM, is illustrated by the following scheme:
CHAAn CHDAAM
β -Substituted glutaramic acid can be prepared by: a) Partial hydrolysis of the corresponding diethyl glutarate, followed by reaction with ammonia and subsequent acidification - see G. H. Jeffery et al., Chem. Soc, p. 1101 (1934). b) Hydrolysis of the corresponding glutarimide with one equivalent of NaOH, followed by acidification - see G. J. Handley et al, "Compounds derived from β-substituted glutaric acids". Aust. J. Chem., pp. 135, 140, 143, (1960)
It is known in the literature to prepare glutaric anhydrides by refluxing glutaric acids with excess acetic anhydride for several hours, concentrating and finally distilling under reduced pressure (see G.J. Handley et al., "Compounds derived from β-substituted glutaric acids", Aust. J. Chem., 129-144 (I960)).
While USP 4,024,175 merely states that the crude 1,1-cyclopentenediacetic acid monoamide, obtained and described therein, can be further worked up directly, it does not describe such work-up and does not specify the yield and the degree of purity of the final product. The art does not teach an efficient way of carrying out the work-up, and as a result does not provide an efficient complete process for the production of CHDAAM.
It is therefore a purpose of this invention to .provide such a complete process, which produces pure CHDAAM in satisfactory yields and with very high purity.
It is another purpose of this invention to provide such a process which is simple, efficient, and reduces the number of operations required.
Summary of the Invention
The process of the invention comprises the steps of: a) amination of CHDAAn with aqueous ammonia; b) neutralization of the reaction mixture, whereby crude CHDAAM is precipitated and filtered; and c) purification of the crude CHDAAM by crystallization from a solvent.
Preferably: a) the amination is carried out at a temperature kept below 20°C and with aqueous ammonia having a concentration from 25 to 35 wt%, in a molar ratio relative to the CHDAAn from 5 to 10;
b) the neutralization is carried out with an aqueous solution of H2SO4 having a concentration from 30 to 60 wt% and is continued until a slightly acid solution is obtained; c) the solvent of the crystallization is aq. acetonitrile and the crystallized product is washed with the same solvent and dried.
The pure CHDAAM is obtained in a yield of at least 75 mole% over the starting CHDAAn, and with a purity typically above 99%, e.g. 99.5 or more percent. CHDAAM having such a high purity is a new product, since the art does not teach how to achieve it, and as such constitutes an aspect of this invention.
Alternatively, in less preferred embodiments of the invention, the neutralization of the reaction mixture can be carried out with aqueous hydrochloric acid, with or without a previous evaporation of the excess ammonia. In any case, the CHDAAM precipitates when the solution is slightly acid.
Brief Description of the Drawings
In the drawings:
Fig. 1 is a flow sheet illustrating the steps of the preparation of crude CHDAAM from CHDAAn; and
Fig. 2 is a flow sheet illustrating the purification of the crude CHDAAM thus obtained.
Detailed Description of Preferred Embodiments
A preferred embodiment of the process of the invention will be described with reference to the flow sheets of the drawings.
Melted crude CHDAAn at 50-70°C, or a solution of CHDAAn in a minimal amount of methylisobutylketone (MIBK), is added to a cold, 28 wt% aqueous solution of NHs- The molar ratio NH3: CHDAAn is about 7. The addition of the CHDAAn is carried out at such a rate that it is completed in 2 to 5 hours. In the specific example herein described, 0.8 moles of CHDAAn are added to 5.85 moles of NH3 in a period of time of 2 hours.
The reaction is exothermic and therefore the reactor must be cooled to keep the temperature of the reaction mass below 20°C. The progress of the reaction is monitored by HPLC. The reaction is very fast and is practically complete immediately after the completion of the addition of the CHDAAn. The reaction mixture is obtained in the form of a clear solution. The final concentration of NH3 is checked in order to calculate the amount of acid required in the neutralization stage.
The neutralization is then carried out: in the preferred example herein described, it is carried out with aqueous 50wt% H2SO4 without prior evaporation of the excess ammonia. In the specific example herein described, 337 ml of the said aqueous, 50% w/w H2SO4 are used for the neutralization. During the neutralization, the temperature is maintained below 30°C. The precipitation of crude CAM starts at pH 7-8 and is complete at pH about 5.
The crude CAM is separated by filtration from the slurry generated in the neutralization stage. It is washed with water and the crude material thus obtained is analyzed by HPLC.
Various solvents can be used for crystallization of the crude CHDAAM but aq. acetonitrile is preferred because it dissolves the organic impurities and because the crystallization yields and throughput are higher than with other solvents. The aq. acetonitrile contains 2 to 25 wt% of water, preferably 1 wt%. Other organic solvents such as, e.g., methanol or methylisobutylketone, could however be used. When aq. acetonitrile is used, its weight ratio thereof to the wet, crude CHDAAM, in the example herein described, is preferably about 1 to 4, more preferably 2.
After crystallization and filtration, the wet cake of CHDAAM is washed with the crystallization solvent, preferably acetonitrile, and dried.
The pure CHDAAM thus obtained has a purity higher than 99.5% and is obtained in a yield of about 75%, based on CHDAAn.
The CHDAAn used as a starting material in the above process can be obtained in ways known in the art. For instance, it can be obtained by reacting CHDAA with excess acetic anhydride under reflux, followed by distillation of the excess acetic anhydride and acetic acid formed from the reaction mixture and final distillation, according to the following reaction scheme:
CHDAAn
Although the preparation of CHDAAn from CHDAA is not a part of the invention, the following references are given for illustrative purposes:
1. French Patent 1,248,764, Spiro(cyclohexane-l,4'-glutarimides), Centre de Lyophilisation Pharmaceutique (1961), CA 57:3320.
2. J. F. Callahan et al., Synthesis of 6,6-pentamethylene-2-aminosuberic acid, a key intermediate in the synthesis of dicarba analogues of Vasopressin antagonists, J. Org. Chem., 53, 1527-1530 (1988), CA 108: 150949.
While embodiments of the invention have been described for purposes of illustration, it will be understood that they are not limitative and that the invention may be carried out with a number of modifications, variations and adaptations, without departing from its spirit or exceeding the scope of the claims.